In today’s “AARP Minute,” how some people taking chemotherapy drugs are saving thousands of dollars, plus a new poll shows a ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...

While Verzenio, a drug in the same class, has been approved to lower the risk of early breast cancer returning, it's only for ...

Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the ...

A recent survey from AARP found that roughly 40 percent of adults age 65-plus who are eligible for Medicare have either ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal in a late-stage study in ...

A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

Research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer ...

Dame Esther Rantzen has revealed her cancer is currently being “kept at bay” thanks to a new drug. The 84-year-old ...